StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.40+0.19 (+3.06%)

Close on Nov 18, 2026Market cap $288.13MP/E –Yield –

Agenus price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Agenus's price to book ratio was 3.7× on Oct 31, 2022, against 403.7× a year earlier. Over the last 2 years it ranged from 0.2× to 403.7×, with a median of 70.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Oct 31, 20223.7×+3.3
2021Dec 31, 20210.3×−403.4
2016Oct 31, 2016403.7×+318.1
2015Dec 31, 201585.7×–

More Agenus figures

See a number that looks wrong?